|1.||Fang, Jun: 3 articles (08/2007 - 07/2003)|
|2.||Maeda, Hiroshi: 3 articles (08/2007 - 07/2003)|
|3.||Fang, J: 2 articles (08/2007 - 09/2002)|
|4.||Greish, Khaled: 2 articles (08/2007 - 03/2004)|
|5.||Maeda, H: 2 articles (03/2007 - 09/2002)|
|6.||Akaike, Takaaki: 2 articles (03/2004 - 07/2003)|
|7.||Sawa, Tomohiro: 2 articles (03/2004 - 07/2003)|
|8.||Seki, Takahiro: 1 article (08/2007)|
|9.||Iyer, Arun K: 1 article (08/2007)|
|10.||Iyer, A K: 1 article (08/2007)|
03/01/2004 - "PEG-ZnPP is a water-soluble HO inhibitor that accumulates in tumor tissues after intravenous administration. "
07/01/2003 - "These findings suggest that tumor-targeted inhibition of HO activity could be achieved by using PEG-ZnPP, which induces apoptosis in solid tumors, probably through increased oxidative stress."
07/01/2003 - "The major reason for tumor-selective targeting of PEG-ZnPP is attributed to the enhanced permeability and retention effect that is observed commonly in solid tumors for biocompatible macromolecular drugs. "
07/01/2003 - "In addition, this PEG-ZnPP treatment produced tumor-selective suppression of HO activity as well as induction of apoptosis. "
07/01/2003 - "More important, PEG-ZnPP preferentially accumulated in solid tumor tissue in a murine model. "
|2.||T-Cell Leukemia (Leukemia, T Cell)
|2.||Ethylene Glycol (Monoethylene Glycol)
|4.||Heme Oxygenase (Decyclizing) (Heme Oxygenase)
|5.||copoly(styrene-maleic acid)-zinc protoporphyrin
|6.||pegylated zinc protoporphyrin
|7.||Reactive Oxygen Species (Oxygen Radicals)
|8.||Oxidants (Oxidizing Agents)
|10.||D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)